Temporal trajectories of long-COVID symptoms in adults with 22 months follow-up in a prospective cohort study in Norway

Int J Infect Dis. 2024 Dec:149:107263. doi: 10.1016/j.ijid.2024.107263. Epub 2024 Oct 15.

Abstract

Objectives: There is a lack of large studies on long-COVID symptoms with symptoms measurements before the onset of COVID-19. Therefore, long-COVID is still poorly defined.

Methods: The Norwegian COVID-19 Cohort Study is a population-based, open cohort of adult participants (aged 18-96 years) from Norway. From March 27, 2020, participants were recruited through social media, invitations, and nationwide media coverage. Fourteen somatic and cognitive symptoms were assessed at baseline and four follow-ups for up to 22 months. SARS-CoV-2 test status was obtained from a mandatory national registry or from self-report.

Results: After follow-up, 15 737 participants had a SARS-CoV-2-positive test, 67 305 had a negative test, and 37 563 were still untested. Persistent symptoms reported more frequently by positive compared with negative participants one month after infection, were memory problems (3-6 months: adjusted odds ratio (aOR) = 6.8, CI = 5.7-8.1; >18 months: aOR = 9.4, CI = 4.1-22), and concentration problems (3-6 months: aOR = 4.1, CI = 3.5-4.7; >18 months: aOR = 4.4, CI = 2.0-9.7) as well fatigue, dyspnea, anosmia and dysgeusia.

Conclusions: COVID-19 was associated with cognitive symptoms, anosmia, dysgeusia, dyspnea, and fatigue as well as worsening of overall health up to 22 months after a SARS-CoV-2 test, even when correcting for symptoms before the onset of COVID-19.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anosmia / epidemiology
  • Anosmia / physiopathology
  • COVID-19* / diagnosis
  • COVID-19* / epidemiology
  • Fatigue
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Norway / epidemiology
  • Post-Acute COVID-19 Syndrome
  • Prospective Studies
  • SARS-CoV-2*
  • Young Adult